D ’Alise AM, Brasu N, De Intinis C, Leoni G, Russo V, Langone F, et al. Adenoviral-based vaccine promotes neoantigen-speci ﬁc CD8( þ) T cell stemness and tumor rejection. Sci Transl Med 2022;14:eabo7604.